Application 076225
- Type
- ANDA
- Sponsor
- MAYNE PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ERRIN | NORETHINDRONE | TABLET;ORAL-28 | 0.35MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0555-0344 | Errin | Norethindrone | Teva Pharmaceuticals USA, | ANDA | Current |
| 51862-100 | Errin | Norethindrone | Mayne Pharma Inc. | ANDA | Current |
| 51862-886 | ERRIN | NORETHINDRONE | Mayne Pharma Inc. | ANDA | Current |
| 51862-886 | ERRIN | NORETHINDRONE | Mayne Pharma Inc. | ANDA | Current |
| 71205-526 | ERRIN | NORETHINDRONE | Proficient Rx LP | ANDA | Current |